scholarly journals Barriers and Drivers Regarding the Use of Mobile Health Applications Among Patients With Type 2 Diabetes Mellitus in the Netherlands: an Explanatory Sequential Design (Preprint)

JMIR Diabetes ◽  
10.2196/31451 ◽  
2021 ◽  
Author(s):  
Marloes Bults ◽  
Catharina Margaretha van Leersum ◽  
Theodorus Johannes Josef Olthuis ◽  
Robin Enya Marije Bekhuis ◽  
Marjolein Elisabeth Maria den Ouden
2020 ◽  
Author(s):  
Esrat Jahan ◽  
Rawan Almansour ◽  
Kiran Ijaz ◽  
Rimante Ronto ◽  
Liliana Laranjo

Diabetes mellitus is a leading cause of concern among non-communicable diseases worldwide, with its prevalence increasing every day. Studies have shown that it is possible to prevent type 2 diabetes in high risk people if they adopt a healthy lifestyle, such as exercising regularly, eating nutritious food and maintaining an ideal weight. Mobile apps may aid these people in maintaining a healthy lifestyle. Till date, no systematic review has evaluated the use of mobile health applications for the prevention of type 2 diabetes. In this systematic review protocol we will lay out the methods we will use to synthesise the evidence about mobile health applications for the prevention of type 2 diabetes, focusing particularly on their impact on different process and outcome measures, as well as on patient perspectives. Database searches will be done in PubMed, Embase, CINAHL and PsychInfo. Screening of the articles will be conducted by two independent researchers. The Cochrane risk of bias tool will be used for quality assessment. A narrative synthesis of the included articles will be done and the results summarised. The findings of this review will provide evidence on the impact of mobile applications in preventing Type 2 diabetes mellitus.


Author(s):  
Wahyu Sukma Samudera ◽  
Novita Fajriyah ◽  
Ida Trisnawati

Background: Type 2 diabetes mellitus was one of non-communicable diseases that increased of prevalence in word wide, included in Indonesia. Utilization of technology as an effort of increase of diabetes treatment is important for achieving of optimum glycemic control and to prevent of complication of diabetes mellitus. However, intervention for self management in patients with diabetes mellitus at this time still not using technology based mobile health intervention. Purpose: This study aims to verify of effectiveness of mobile health intervention on self management and glycemic control in patient with type 2 diabetes mellitus. Method: Design of this studies was used systematic review of randomized controlled trial with PRISMA approach. Article search was carried out through databases: Scopus, Science Direct, and ProQuest with randomized controlled trial design within last 10 years. Results: The finding showed 407 articles have been obtained. Articles selection process were through few steps: topic selection, full text selection, design of studies and obtained 10 articles have been as appropriate of inclusion criteria. Based on results of finding of 10 articles were showed that mobile health intervention was effective in improving of glycemic control by decreasing hbA1c, fasting blood glucose, 2 hours post pandrial. Furthermore, mobile health intervention was effective in increasing of self management in patient with type 2 diabetes mellitus and increased adherence of diabetes medication. Moreover, mobile health intervention can also improve of insulin level and lipid profile in patient with type 2 diabetes mellitus. Conclusion: Mobile health intervention was effective in improving of glycemic control and self management, and giving of facilitate communication between patient and health providers Keywords: mobile health application; self management; glycemic control; diabetes mellitus ABSTRAK Latar belakang: diabetes melitus (DM) tipe 2 merupakan salah satu penyakit tidak menular yang mengalami peningkatan angka kejadian di dunia, termasuk di Indonesia. Penggunaan teknologi sebagai upaya meningkatkan manajemen diabetes melitus sangatlah penting untuk dilakukan guna mencapai kontrol glikemik optimal dan mencegah komplikasi dari Diabetes Melitus. Namun, manajemen diri pada sebagian besar pasien Diabetes Melitus saat ini masih belum menggunakan bantuan teknologi berbasis mobile health. Tujuan: Penelitian ini bertujuan untuk memverifikasi efektivitas dari penggunaan mobile health intervention terhadap manajemen diri dan kontrol glikemik pasien dengan diabetes melitus tipe 2. Metode: desain dalam penelitian ini adalah systematic review dengan menggunakan pendekatan PRISMA. Pencarian artikel dilakukan pada beberapa database yang meliputi: Scopus, Science Direct dan ProQuest dengan desain Randomized controlled trial dalam 10 tahun terakhir. Hasil: hasil temuan didapatkan sejumlah 407 artikel penelitian. Proses seleksi artikel dilakukan beberapa tahap meliputi: seleksi topik, fullteks, desain artikel penelitian dan didapatkan 10 artikel penelitian yang sesuai dengan kriteria inklusi. Berdasarkan hasil temuan dari 10 artikel penelitian yang digunakan, menunjukkan bahwa mobile health intervention efektif dalam memperbaiki kontrol glikemik pasien diabetes melalui penurunan kadar hbA1c, gula darah puasa, 2 jam post pandrial. Selanjutnya, mobile health intervention efektif dalam meningkatkan manajemen diri pasien diabetes dan meningkatkan kepatuhan pengobatan. Selain itu, mobile health intervention juga dapat memperbaiki level insulin dan profil lipid pasien diabetes melitus tipe 2. Kesimpulan: Mobile health intervention efektif dalam memperbaiki kontrol glikemik dan meningkatkan manajemen diri pasien diabetes melitus serta memudahkan komunikasi antara pasien dengan tenaga kesehatan Kata kunci: mobile health application; manajemen diri; kontrol glikemik; diabetes melitus


2021 ◽  
Author(s):  
Marloes Bults ◽  
Catharina Margaretha Van Leersum ◽  
Theo Olthuis ◽  
Robin Bekhuis ◽  
Marjolein Elisabeth Maria Den Ouden

BACKGROUND In the Netherlands, type 2 diabetes mellitus (T2DM) is one of the most common chronic diseases and the number of patients is expected to increase in the coming years. Self-monitoring of blood glucose levels, food intake and physical activity supports the self-management of patients with T2DM. In the past few years, there has been a rise in the development and availability of mobile health applications (apps) for T2DM. OBJECTIVE The aim of this study was to explore the actual use of diabetes mobile health applications among T2DM-patients and main barriers and drivers among app-users and non-users. METHODS An explanatory sequential design was applied, starting with a web-based questionnaire followed by semi-structured in-depth interviews. Data were collected between July and December 2020. Questionnaire data from 103 respondents were analyzed using IBM SPSS Statistics 25.0. Descriptive statistics were performed for actual use of apps among T2DM-patients and the individual items of the Unified Theory of Acceptance and Use of Technology (UTAUT). Differences between users and non-users were tested through chi-square tests for the individual items. Independent t-tests were performed to test for differences in mean scores per UTAUT-construct. A total of 16 respondents contributed to the in-depth interviews, of which ten were users and six non-users of apps for T2DM. Content analysis with a deductive approach was performed on all transcripts guided by the UTAUT. RESULTS Regarding actual use, 55% (n=57) were non-users and 45% (n=46) were users of apps for T2DM. Mean scores were significantly higher among users of apps for T2DM for the constructs performance expectancy, effort expectancy, facilitating conditions and knowledge compared to the non-users (P<.001). One of the main drivers for use was the belief that using diabetes-apps would result in better personal health and well-being. Time and energy needed to keep track of data and understand the app were mentioned as barriers. Users scored significantly higher regarding social influence compared to the non-users (P.007). Healthcare professionals play an important role in the support of T2DM-patients in using apps. Respondents wanted to use the apps and acquired data together with their healthcare professionals. However, respondents noticed that their professionals often were not supportive regarding the use of diabetes-apps, didn’t had interest or did not talk about apps or acquired data. Reimbursement by insurance companies was mentioned as missing facilitator. CONCLUSIONS Empowering healthcare professionals’ engagement is of utmost important to support T2DM-patients in using apps. Insurance companies can have a role in facilitating the use of diabetes-apps, for example to assure reimbursement. Further research should focus on evaluation of patients experiences with different diabetes-apps and how to integrate mobile health applications with diabetes self-management care.


BMJ Open ◽  
2019 ◽  
Vol 9 (6) ◽  
pp. e025714 ◽  
Author(s):  
Benard Ayaka Bene ◽  
Siobhan O’Connor ◽  
Nikolaos Mastellos ◽  
Azeem Majeed ◽  
Kayode Philip Fadahunsi ◽  
...  

IntroductionThe emergence of mobile health (mHealth) solutions, particularly mHealth applications (apps), has shown promise in self-management of chronic diseases including type 2 diabetes mellitus (T2DM). While majority of the previous systematic reviews have focused on the effectiveness of mHealth apps in improving treatment outcomes in patients with T2DM, there is a need to also understand how mHealth apps influence self-management of T2DM. This is crucial to ensure improvement in the design and use of mHealth apps for T2DM. This protocol describes how a systematic review will be conducted to determine in which way(s) mHealth apps might impact on self-management of T2DM.MethodsThe following electronic databases will be searched from inception to April 2019: PubMed, MEDLINE, EMBASE, Global Health, PsycINFO, CINAHL, The Cochrane Central Register of Controlled Trials, Scopus, Web of Science, ProQuest Dissertations & Theses Global, Health Management Information Consortium database, Google Scholar and ClinicalTrials.gov. The Cochrane risk of bias tool will be used to assess methodological quality. The primary outcome measures to be assessed will be ‘change in blood glucose’. The secondary outcomes measures will be ‘changes in cardiovascular risk markers’ (including blood pressure, body mass index and blood lipids), and self-management practices. Others will include: health-related quality of life, economic data, social support, harms (eg, death or complications leading to hospital admissions or emergency unit attendances), death from any cause, anxiety or depression and adverse events (eg, hypoglycaemic episodes).Ethics and disseminationThis study will not involve the collection of primary data and will not require ethical approval. The review will be published in a peer-reviewed journal and a one-page summary of the findings will be shared with relevant organisations. Presentation of findings will be made at appropriate conferences.Trial registration numberCRD42017071106.


PLoS ONE ◽  
2019 ◽  
Vol 14 (9) ◽  
pp. e0221856 ◽  
Author(s):  
Alexander V. van Schoonhoven ◽  
Judith J. Gout-Zwart ◽  
Marijke J. S. de Vries ◽  
Antoinette D. I. van Asselt ◽  
Evgeni Dvortsin ◽  
...  

2013 ◽  
Vol 34 (2) ◽  
pp. 135-146 ◽  
Author(s):  
Heleen G. M. van Haalen ◽  
Marjolein Pompen ◽  
Klas Bergenheim ◽  
Phil McEwan ◽  
Rebecca Townsend ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document